APA (7th ed.) Citation

Sapina, A. I., Varlamova, Y. Y., Papyrina, M. G., Bezymyannyy, A. S., Kordzaya, E. L., & Vasilyeva, E. Y. (2025). Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Sapina, A. I., Yu. Yu Varlamova, M. G. Papyrina, A. S. Bezymyannyy, E. L. Kordzaya, and E. Yu Vasilyeva. Evaluation of Lipoprotein(a) — a Novel Cardiovascular Risk Factor in Patients with Atherosclerotic Cardiovascular Diseases Receiving PCSK9-targeted Therapy in Russian Real-world Practice. «FIRMA «SILICEA» LLC, 2025.

MLA (9th ed.) Citation

Sapina, A. I., et al. Evaluation of Lipoprotein(a) — a Novel Cardiovascular Risk Factor in Patients with Atherosclerotic Cardiovascular Diseases Receiving PCSK9-targeted Therapy in Russian Real-world Practice. «FIRMA «SILICEA» LLC, 2025.